-
Share buybacks in Ericsson during the period September 7 – September 11, 2026
-
Sungrow PhD Talk Outlines 5 Key Trends in Offshore Renewables
-
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
-
Italy National Pavilion Shines at the 26th China International Fair for Investment and Trade
-
Systecon launches new release of Opus Suite+, marking a step-change beyond OPUS10 and SIMLOX for the first time
-
NUS scientists harness magnetic pulses to reprogram immune cells to fight breast cancer
-
Thunes Launches Cross-Border Payouts Across Six New Middle East Markets
-
Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland
